cycloheximide has been researched along with Disease Exacerbation in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 7 (50.00) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, HN; Chen, KC; Chuang, YT; Hung, SH; Lai, JK; Lan, CH; Liang, KH; Liao, MY; Tsuei, WW; Wu, HC | 1 |
| Cho, SS; Ki, SH; Kim, KM | 1 |
| Cao, H; Ren, SN; Tian, XF; Zang, HL | 1 |
| Gao, P; Liu, HT; Liu, L; Liu, S; Ma, RR | 1 |
| Adams, BD; Claffey, KP; White, BA | 1 |
| Boddeke, E; den Dunnen, WF; Duarri, A; Fokkens, M; Hageman, G; Jezierska, J; Kampinga, HH; Kremer, B; Küsters, B; Meijer, M; Schelhaas, HJ; Sinke, RJ; Swertz, MA; van de Vlies, P; van de Warrenburg, BP; van Dijk, F; Verbeek, DS; Verschuuren-Bemelmans, C; Wijmenga, C | 1 |
| Vigneswaran, N; Wu, J; Zacharias, W | 1 |
| Auger, A; Bertoglio, J; Liot, C; Loirand, G; Mzali, R; Pacaud, P; Pierre, J; Seguin, L; Thibault, C | 1 |
| Bao, S; Liu, DJ; Liu, XY; Mal, SF; Miao, DQ; Tan, JH | 1 |
| Amoss, MS; Fadok, V; Gossett, R; Kier, AB; McConkey, D; Schroeder, F | 1 |
| Dawson, DM; Hafler, DA; Hohol, MJ; Khoury, SJ; Olek, MJ; Orav, EJ; Stazzone, L; Weiner, HL | 1 |
| Hurta, RA; Kim, M; Voskas, D | 1 |
| Barnes, CJ; Kumar, R; Li, F; Mandal, M; Vadlamudi, RK | 1 |
| Keshamouni, VG; Mattingly, RR; Reddy, KB | 1 |
1 review(s) available for cycloheximide and Disease Exacerbation
| Article | Year |
|---|---|
Emerging roles of ferroptosis in liver pathophysiology.
Topics: Animals; Antineoplastic Agents; Caffeic Acids; Carcinoma, Hepatocellular; Cycloheximide; Cyclohexylamines; Deferoxamine; Disease Models, Animal; Disease Progression; Fatty Acids, Unsaturated; Ferroptosis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iron; Lipid Peroxidation; Liver; Liver Cirrhosis; Liver Failure; Liver Neoplasms; Non-alcoholic Fatty Liver Disease; Phenylenediamines; Quinoxalines; Reactive Oxygen Species; Reperfusion Injury; Spiro Compounds | 2020 |
13 other study(ies) available for cycloheximide and Disease Exacerbation
| Article | Year |
|---|---|
EpCAM Signaling Promotes Tumor Progression and Protein Stability of PD-L1 through the EGFR Pathway.
Topics: Animals; Antibodies, Monoclonal, Humanized; Antibodies, Neutralizing; Antigens, Neoplasm; Antineoplastic Agents; Apoptosis; B7-H1 Antigen; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cell Nucleus; Colorectal Neoplasms; Cycloheximide; Disease Progression; Enzyme Activation; Epithelial Cell Adhesion Molecule; ErbB Receptors; Forkhead Box Protein O3; Heterografts; High-Temperature Requirement A Serine Peptidase 2; Humans; Mice; Mitogen-Activated Protein Kinases; Neoplasm Transplantation; Phosphorylation; Programmed Cell Death 1 Receptor; Protein Domains; Protein Stability; Protein Synthesis Inhibitors; Proto-Oncogene Proteins c-akt; Signal Transduction; Up-Regulation | 2020 |
The ubiquitin ligase TRIM25 inhibits hepatocellular carcinoma progression by targeting metastasis associated 1 protein.
Topics: Atlases as Topic; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Cell Movement; Cycloheximide; Disease Progression; Gene Expression Regulation, Neoplastic; Half-Life; Hepatocytes; Histone Deacetylases; Humans; Leupeptins; Liver Neoplasms; Protein Binding; Protein Stability; Proteolysis; Repressor Proteins; RNA, Small Interfering; Signal Transduction; Trans-Activators; Transcription Factors; Tripartite Motif Proteins; Ubiquitin-Protein Ligases; Ubiquitination | 2017 |
EGR1-Mediated Transcription of lncRNA-HNF1A-AS1 Promotes Cell-Cycle Progression in Gastric Cancer.
Topics: Animals; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclin E; Cyclin-Dependent Kinase 4; Cycloheximide; Dactinomycin; Disease Progression; Early Growth Response Protein 1; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Nude; MicroRNAs; Neoplasm Invasiveness; Neoplasm Transplantation; Oncogene Proteins; Promoter Regions, Genetic; RNA, Antisense; RNA, Long Noncoding; RNA, Small Interfering; Stomach Neoplasms; Ubiquitin-Conjugating Enzymes | 2018 |
Argonaute-2 expression is regulated by epidermal growth factor receptor and mitogen-activated protein kinase signaling and correlates with a transformed phenotype in breast cancer cells.
Topics: Argonaute Proteins; Breast Neoplasms; Cell Aggregation; Cell Movement; Cell Transformation, Neoplastic; Cycloheximide; Disease Progression; ErbB Receptors; Eukaryotic Initiation Factor-2; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Phenotype; Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Wound Healing | 2009 |
Mutations in potassium channel kcnd3 cause spinocerebellar ataxia type 19.
Topics: Aged; Aged, 80 and over; Brain; Case-Control Studies; Chromatin Immunoprecipitation; Cycloheximide; Disease Progression; DNA Mutational Analysis; Family Health; Female; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; HEK293 Cells; HeLa Cells; Humans; Luminescent Proteins; Male; Membrane Potentials; Mutation, Missense; Patch-Clamp Techniques; Protein Synthesis Inhibitors; Shal Potassium Channels; Silver Staining; Spinocerebellar Degenerations; Time Factors; Transfection | 2012 |
Upregulation of cystatin M during the progression of oropharyngeal squamous cell carcinoma from primary tumor to metastasis.
Topics: Apoptosis; Biomarkers, Tumor; Blotting, Western; Camptothecin; Carcinoma, Squamous Cell; Cathepsin B; Cell Line; Cycloheximide; Cystatin M; Cystatins; Cytotoxicity Tests, Immunologic; Disease Progression; DNA Fragmentation; Enzyme Inhibitors; Humans; Immunohistochemistry; In Situ Hybridization; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha | 2003 |
Regulation of Rho signaling pathways in interleukin-2-stimulated human T-lymphocytes.
Topics: Blotting, Western; CD4-Positive T-Lymphocytes; Cell Cycle; Cell Line; Cell Proliferation; Cycloheximide; Disease Progression; Flow Cytometry; Gene Expression Regulation; GTPase-Activating Proteins; Guanine Nucleotide Exchange Factors; Humans; Immune System; Interleukin-2; Nucleic Acid Hybridization; Oligonucleotide Array Sequence Analysis; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; rho GTP-Binding Proteins; Rho Guanine Nucleotide Exchange Factors; RNA, Messenger; Signal Transduction; T-Lymphocytes; Time Factors | 2005 |
Cortical granules behave differently in mouse oocytes matured under different conditions.
Topics: Agglutinins; Animals; Cell Nucleus; Culture Media; Cycloheximide; Cytoplasm; Cytoplasmic Granules; Disease Progression; Embryo Culture Techniques; Fertilization in Vitro; Fluorescein-5-isothiocyanate; Hypoxanthine; Lens Plant; Meiosis; Mice; Microscopy, Confocal; Models, Genetic; Oocytes; Protein Synthesis Inhibitors; Time Factors; Zona Pellucida | 2005 |
Cycloheximide-induced apoptosis in melanoma cells derived from regressing cutaneous tumours of Sinclair swine.
Topics: Animals; Apoptosis; Cycloheximide; Disease Progression; Melanoma; Neoplasm Regression, Spontaneous; Skin Neoplasms; Swine; Swine Diseases; Tumor Cells, Cultured | 1996 |
Treatment of progressive multiple sclerosis with pulse cyclophosphamide/methylprednisolone: response to therapy is linked to the duration of progressive disease.
Topics: Adult; Age of Onset; Cycloheximide; Databases, Factual; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Multiple Sclerosis; Recurrence; Retrospective Studies; Time Factors; Treatment Failure | 1999 |
Platelet-derived growth factor mediated altered expression and regulation of ornithine decarboxylase in H-ras-transformed cell lines.
Topics: Animals; Blotting, Northern; Cell Line; Cell Line, Transformed; Cycloheximide; Disease Progression; Dose-Response Relationship, Drug; Enzyme Inhibitors; Mice; Ornithine Decarboxylase; Pertussis Toxin; Platelet-Derived Growth Factor; Protein Kinase C; Protein Synthesis Inhibitors; Proto-Oncogene Proteins p21(ras); RNA Processing, Post-Transcriptional; RNA, Messenger; Signal Transduction; Time Factors; Transcription, Genetic; Transfection; Virulence Factors, Bordetella | 2001 |
Growth factor regulation of the molecular chaperone calnexin.
Topics: Breast Neoplasms; Calcium-Binding Proteins; Calnexin; Cell Membrane; Cycloheximide; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Humans; Microscopy, Confocal; Molecular Chaperones; Neuregulin-1; Oligonucleotide Array Sequence Analysis; Protein Synthesis Inhibitors; Protein Transport; Receptor, ErbB-2; RNA, Messenger; Transcriptional Activation; Tumor Cells, Cultured | 2001 |
Mechanism of 17-beta-estradiol-induced Erk1/2 activation in breast cancer cells. A role for HER2 AND PKC-delta.
Topics: Blotting, Western; Breast Neoplasms; Cell Division; Cycloheximide; Disease Progression; DNA, Complementary; Enzyme Activation; ErbB Receptors; Estradiol; Genes, Dominant; Humans; Isoenzymes; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Models, Biological; Monomeric GTP-Binding Proteins; Neuregulin-1; Precipitin Tests; Protein Binding; Protein Kinase C; Protein Kinase C-delta; Protein Synthesis Inhibitors; Receptor, ErbB-2; Signal Transduction; Time Factors; Transfection; Transforming Growth Factor alpha; Tumor Cells, Cultured | 2002 |